CombiSep Appoints NanoChrom as West Coast Representative
News Dec 20, 2005
CombiSep, Inc. has recently appointed NanoChrom, LLC as its representative for the West Coast.
Mark McDonald, Chief Executive Officer of CombiSep, anticipates the relationship with NanoChrom saying, "I am extremely pleased that NanoChrom will be serving our western U.S. customers."
He adds, "Mr. Terry Ochsner, President of NanoChrom, has extensive sales and service experience in separation science instrumentation and has served in key leadership positions within Hitachi High Technologies America and Merck KGaA."
"Terry’s company will provide vital local representation in a very strategic geographical market for CombiSep’s CE-based life science solutions."
Mr. Terry Ochsner, President of NanoChrom, LLC said, "I believe that CombiSep’s parallel capillary electrophoresis technology has great potential in the life science marketplace, and I look forward to expanding the presence of CombiSep throughout the West Coast."
"I view CombiSep as a key addition to the companies NanoChrom represents in our quest to provide unique system solutions and services to the life science community."
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE